Details for 2005818127

Up to date per 03.04.2026

Actions

Title / Product Name

KRISTALLINE FORMEN DER VERBINDUNG 4-(6-CHLOR-2,3-METHYLENDIOXYANILINO)-7-[2-(4-METHYLPIPERAZIN-1-YL)ETHOXY]-5-TETRAHYDROPYRAN-4-YLOXYCHINAZOLIN.

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2005818127

EP Publication Number

1871769

E-Number

869155

Language

PCT Number

GB05004807

Publication Date

02.01.2008 A

22.02.2017 B1

Registration Date

22.02.2017

AT Publication Date

15.03.2017

Application Date

14.12.2005

Registration Number

Priorities

17.12.2004

0427697

IPC

C07D 405/12 20060101AFI20060627BHEP

Maximum Duration of Protection

14.12.2025

Owner

AstraZeneca AB 151 85 SödertäljeSE

Representative

No representatives present

Inventor

FORD, James Gair AstraZenecaCharter Way Macclesfield Cheshire SK10 2NAGB

MCCABE, James Francis AstraZenecaCharter Way Macclesfield Cheshire SK10 2NAGB

O'KEARNEY-MCMULLAN, Anne AstraZenecaCharter Way Macclesfield Cheshire SK10 2NAGB

O'KEEFE, Philip AstraZeneca R & D CharnwoodBakewell Road Loughborough Leicestershire LE11 5RHGB

POINTON, Simon Mark AstraZenecaCharter Way Maccl esfield Cheshire SK10 2NAGB

POWELL, Lyn AstraZenecaCharter Way Macclesfield Cheshire SK10 2NAGB

PURDIE, Mark AstraZeneca R & D CharnwoodBakewell Road Loughborough Leicestershire LE11 5RHGB

WITHNALL, Jane AstraZeneca R & D CharnwoodBakewell Road Loughborough Leicestershire LE11 5RHGB